Clinical Trials in Corbeil-Essonnes, France
40 recruiting
Showing 1–20 of 47 trials
Recruiting
French Prospective Multicentric Study in Real World
Diabetes MellitusDiabetesType 1 Diabetes
Insulet Corporation304 enrolled24 locationsNCT07039942
Recruiting
Omnipod-5 A French Prospective Multicentric Study in Real World (Optimal-B)
Diabetes MellitusDiabetesType 1 Diabetes
Insulet Corporation152 enrolled22 locationsNCT07317102
Recruiting
Not Applicable
IPSTRAUC : Impact on Care Pathways of a New Management of Cervical Trauma in Conscious Patients Stable in Pre-hospital Care
Emergency Medical ServicesPrehospital EmergencyNeck Trauma+1 more
Rennes University Hospital840 enrolled12 locationsNCT06983873
Recruiting
Phase 3
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Cardiovascular DiseasesHypertensionDiabetes Mellitus, Type 2
Boehringer Ingelheim11,800 enrolled1152 locationsNCT07064473
Recruiting
Phase 3
A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)
Diabetes Mellitus, Type 1
Eli Lilly and Company300 enrolled132 locationsNCT07222332
Recruiting
Phase 3
A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults
Diabetes Mellitus, Type 1
Eli Lilly and Company150 enrolled107 locationsNCT07222137
Recruiting
Phase 3
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
Cardiovascular Disease
AstraZeneca15,100 enrolled1264 locationsNCT07000357
Recruiting
Not Applicable
MOLECULAR BASIS OF LANGUAGE DEVELOPMENT AND ASSOCIATED DISORDERS
Developmental Language Disorder
Institut National de la Santé Et de la Recherche Médicale, France50 enrolled3 locationsNCT06660108
Recruiting
Phase 3
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular RiskAcute Myocardial Infarction (AMI)
Novo Nordisk A/S10,000 enrolled970 locationsNCT06118281
Recruiting
Not Applicable
Role of High-Throughput Whole Genome Sequencing for the Diagnosis and Care of Atypical Diabetes
Diabetes Mellitus
Institut National de la Santé Et de la Recherche Médicale, France1,020 enrolled26 locationsNCT06570278
Recruiting
Phase 2
FrexalimAB in Preservation of Endogenous insULIN Secretion Compared to Placebo in adUlts and Adolescents on Top of inSulin Therapy (FABULINUS)
Type 1 Diabetes Mellitus
Sanofi192 enrolled80 locationsNCT06111586
Recruiting
Not Applicable
Impact on Mortality of a Strategy Including Continuous Positive Airway Pressure Plus High Flow Nasal Cannula Oxygen Therapy Versus High Flow Nasal Cannula Oxygen Therapy Alone in Patients With de Novo Acute Hypoxemic Respiratory Failure: a Prospective, Randomized Controlled Trial.
De Novo Hypoxemic Acute Respiratory Failure (hARF)
Assistance Publique - Hôpitaux de Paris1,084 enrolled29 locationsNCT06213168
Recruiting
Cohort of Patients With Chronic Myelomonocytic Leukemia
LeukemiaMyelomonocytic Leukemia, Chronic
Gustave Roussy, Cancer Campus, Grand Paris5,000 enrolled24 locationsNCT07512882
Recruiting
Phase 3
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Heart Failure
AstraZeneca11,300 enrolled928 locationsNCT06677060
Recruiting
Phase 3
Elranatamab/Lenalidomide Consolidation and/or Elranatamab Maintenance Versus Standard of Care After D-VRd Induction in Transplant-eligible NDMM Patients
Multiple Myeloma, Newly Diagnosed
Intergroupe Francophone du Myelome824 enrolled64 locationsNCT06918002
Recruiting
Phase 2
CPX-351 vs Intensive Chemotherapy in Patients With de Novo Intermediate or Adverse Risk AML Stratified by Genomics
Acute Myeloid Leukemia
Centre Hospitalier Universitaire de Nice248 enrolled35 locationsNCT05260528
Recruiting
Phase 3
PFO Closure, Oral Anticoagulants or Antiplatelet Therapy After PFO-associated Stroke in Patients Aged 60 to 80 Years
Cryptogenic Ischemic StrokePatent foramen ovale
Assistance Publique - Hôpitaux de Paris792 enrolled42 locationsNCT05387954
Recruiting
Not Applicable
Interventional Clinical Trial Evaluating COVER PATCH CAPTEUR PROTECT Support Solutions for Continuous Glucose Monitoring Sensors in Patients With Diabetes
Diabetes
CAPTEUR PROTECT194 enrolled7 locationsNCT07018180
Recruiting
An Ex-US Study to Assess Treatment Persistence With Risankizumab in Adult Participants With Psoriatic Arthritis
Psoriatic Arthritis
AbbVie1,200 enrolled132 locationsNCT06764693
Recruiting
Prognostic Determinants in Patients With Diabetic Foot Ulcer.
Diabetic Foot Ulcer
University Hospital, Bordeaux1,000 enrolled26 locationsNCT04533152